Institut de Cardiologie de Montréal, Université de Montréal, Montréal, Québec, Canada.
St Paul's Hospital, Centre for Heart Valve Innovation, University of British Columbia, Vancouver, British Columbia, Canada.
Can J Cardiol. 2018 Mar;34(3):330-332. doi: 10.1016/j.cjca.2017.11.007. Epub 2017 Nov 22.
Transcatheter aortic valve implantation (TAVI) is a disruptive technology that has dramatically changed the way clinicians care for patients with aortic stenosis. In 15 short years, this technology has progressed from first-in-human to the standard of care for high-risk and inoperable patients with aortic stenosis. In 2016 the Canadian Cardiovascular Society published the first ever report of quality of care for TAVI in Canada. This report provided multiple insights into evaluating such care delivered to Canadians and the challenges that lie ahead. In this article, we summarize these challenges and encourage cardiologists to join the call to arms for improving quality of TAVI care in Canada.
经导管主动脉瓣植入术（TAVI）是一项颠覆性技术，极大地改变了临床医生治疗主动脉瓣狭窄患者的方式。在短短 15 年内，这项技术已经从首例人体应用发展成为高危和手术不可行的主动脉瓣狭窄患者的标准治疗方法。2016 年，加拿大心血管学会发布了首份关于加拿大 TAVI 护理质量的报告。该报告提供了多个角度来评估加拿大提供的此类护理以及未来面临的挑战。在本文中，我们总结了这些挑战，并鼓励心脏病专家加入呼吁提高加拿大 TAVI 护理质量的行列。
